Remdesivir
Back to searchMolecule Structure
Scientific Name
Remdesivir
Description of the Drug
Remdesivir is a nucleoside analog used to treat RNA virus infections including COVID-19.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB14761
http://www.drugbank.ca/drugs/DB14761
Brand Name(s)
Veklury
Company Owner(s)
Gilead Sciences Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
RNA-directed RNA polymerase L | SINGLE PROTEIN | INHIBITOR | CHEMBL4303062 |
Replicase polyprotein 1ab | SINGLE PROTEIN | INHIBITOR | CHEMBL4523582 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL17712225 |
Human Metabolome Database | HMDB0304869 |
DrugBank | DB14761 |
PubChem | 121304016 |
BindingDB | 429505 |
DrugCentral | 5376 |
Brenda | 237593 |
ChemicalBook | CB53339887 |
Guide to Pharmacology | 10715 |
rxnorm | REMDESIVIR |
ChEBI | 145994 |